OTC Pharmaceuticals - Poland

  • Poland
  • Revenue in the OTC Pharmaceuticals market amounts to US$4,643.00m in 2024. The market is expected to grow annually by 7.59% (CAGR 2024-2029).
  • The market's largest segment is the segment Cold & Cough Remedies with a market volume of US$1,182.00m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$115.40 are generated in 2024.
  • In the OTC Pharmaceuticals market, 15.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Poland has been experiencing steady growth in recent years.

Customer preferences:
Polish consumers have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, OTC medicines are easily accessible and readily available in pharmacies, supermarkets, and online stores. This convenience factor has made OTC medicines a popular choice for minor ailments and self-treatment. Additionally, OTC medicines are often more affordable compared to prescription drugs, making them an attractive option for cost-conscious consumers. Lastly, the increasing awareness and education about self-care and self-medication have also contributed to the growing demand for OTC pharmaceuticals in Poland.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Poland is the growing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking alternative treatments that are perceived as safer and more natural. This trend is driven by a desire to avoid potential side effects associated with conventional medicines. As a result, there has been an increase in the availability and variety of natural and herbal OTC products in the market. Another notable trend is the rising popularity of online sales channels for OTC pharmaceuticals. The convenience of online shopping, coupled with a wide range of product options and competitive pricing, has led to an increase in online purchases of OTC medicines. This trend has been further accelerated by the COVID-19 pandemic, which has prompted consumers to seek contactless shopping options.

Local special circumstances:
Poland has a well-developed healthcare system with a strong emphasis on self-care and self-medication. The country has a long tradition of using herbal remedies and natural treatments, which has influenced consumer preferences in the OTC Pharmaceuticals market. Additionally, the Polish government has implemented policies to promote self-medication and reduce the burden on the healthcare system. This has further contributed to the growth of the OTC Pharmaceuticals market in the country.

Underlying macroeconomic factors:
The growing OTC Pharmaceuticals market in Poland can be attributed to several macroeconomic factors. Firstly, Poland has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. This has allowed consumers to allocate a larger portion of their budget towards healthcare and OTC pharmaceutical products. Furthermore, an aging population and increasing healthcare costs have also played a role in driving the demand for OTC medicines. As the population ages, there is a greater need for self-care and management of chronic conditions, which can be addressed through OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Poland is experiencing growth due to customer preferences for convenience, affordability, and natural remedies. The market is also influenced by local special circumstances, such as a strong emphasis on self-care and government policies promoting self-medication. The underlying macroeconomic factors, including economic growth, an aging population, and increasing healthcare costs, further contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)